How is Physical Activity Measured in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy?

BACKGROUND Physical activity (PA) provides many substantial benefits to help reduce risk for cardiometabolic disease, improve cognitive function, and improve quality of life. Individuals with neuromuscular disorders (NMDs), such as spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) are characterized by muscular weakness and fatigue, which limits the capacity to reach the recommended guidelines of PA. Measuring PA in these populations can provide insight to participation in daily activities, track disease progression, and monitor efficacy of drug treatments. OBJECTIVE The objective of this study was to identify how PA is measured in SMA and DMD using instrumented and self-report methods, and how these methods are employed in ambulatory and non-ambulatory groups. METHODS A scoping review was performed to identify studies that reported PA in these neuromuscular disorders. Inclusion was determined after a multi-stage review process by several reviewers, followed by an in-depth analysis of metrics reported by each tool that was used. RESULTS A total of nineteen studies were identified and included in this review. Sixteen studies included instrumented measures and four studies utilized self-reported measures, with eleven studies also reporting PA information from a non-ambulatory group. A variety of metrics have been reported using both classes of measurement tools. CONCLUSION Although a wide variety of research exists that details both instrumented and self-reported measurement tools, feasibility, cost, and study aims are important factors to consider in addition to testing methodology when selecting which type of tool to use. We recommend using a combination of instrumented and self-report measures to provide context to the PA measured in these populations. Improvements in both instrumented and self-report methodologies will add valuable knowledge about the disease burden and efficacy of treatment and disease management methods in SMA and DMD.

[1]  C. Morse,et al.  Quantitative assessment of sitting time in ambulant adults with Muscular Dystrophy , 2021, PloS one.

[2]  M. Pratt,et al.  Participation of people living with disabilities in physical activity: a global perspective , 2021, The Lancet.

[3]  A. Mayhew,et al.  Wearable Technologies for Children with Chronic Illnesses: An Exploratory Approach , 2021, Therapeutic Innovation & Regulatory Science.

[4]  H. P. van der Ploeg,et al.  The First Global Physical Activity and Sedentary Behavior Guidelines for People Living With Disability. , 2021, Journal of physical activity & health.

[5]  M. Buman,et al.  World Health Organization 2020 guidelines on physical activity and sedentary behaviour , 2020, British Journal of Sports Medicine.

[6]  W. Rooney,et al.  Walking activity in a large cohort of boys with Duchenne muscular dystrophy , 2020, Muscle & nerve.

[7]  M. Buchowski,et al.  Assessing Physical Activity Using Accelerometers in Youth with Duchenne Muscular Dystrophy , 2020, Journal of neuromuscular diseases.

[8]  John P. Buckley,et al.  A comparison of self-reported and device measured sedentary behaviour in adults: a systematic review and meta-analysis , 2020, International Journal of Behavioral Nutrition and Physical Activity.

[9]  B. Damon,et al.  Beyond ambulation: Measuring physical activity in youth with Duchenne muscular dystrophy , 2020, Neuromuscular Disorders.

[10]  I. D. de Groot,et al.  Monitoring daily physical activity of upper extremity in young and adolescent boys with Duchenne muscular dystrophy: A pilot study , 2019, Muscle & nerve.

[11]  Ayse S. Cakmak,et al.  Use of a wearable device to assess sleep and motor function in Duchenne muscular dystrophy , 2019, Muscle & nerve.

[12]  E. Takeshita,et al.  Cumulative jerk as an outcome measure in nonambulatory Duchenne muscular dystrophy , 2019, Brain and Development.

[13]  S. Kriemler,et al.  Accelerometer-derived physical activity estimation in preschoolers – comparison of cut-point sets incorporating the vector magnitude vs the vertical axis , 2019, BMC Public Health.

[14]  M. Greaney,et al.  How Do Physical Activity and Health Vary Among Younger, Middle-Aged, and Older Adults With and Without Disability? , 2019, Journal of aging and physical activity.

[15]  C. Morse,et al.  Relationships between muscle size, strength, and physical activity in adults with muscular dystrophy , 2018, Journal of cachexia, sarcopenia and muscle.

[16]  L. Servais,et al.  Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study , 2018, PloS one.

[17]  C. Buckon,et al.  Longitudinal community walking activity in Duchenne muscular dystrophy , 2018, Muscle & nerve.

[18]  Ulf Ekelund,et al.  A systematic literature review of reviews on techniques for physical activity measurement in adults: a DEDIPAC study , 2018, International Journal of Behavioral Nutrition and Physical Activity.

[19]  Hanns Lochmüller,et al.  Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy – a literature review , 2017, Orphanet Journal of Rare Diseases.

[20]  J. Kleijnen,et al.  The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review , 2017, Orphanet Journal of Rare Diseases.

[21]  Michael Catt,et al.  Measuring Habitual Physical Activity in Neuromuscular Disorders: A Systematic Review , 2017, Journal of neuromuscular diseases.

[22]  M. Jansen,et al.  Physical Activity in Boys With Duchenne Muscular Dystrophy Is Lower and Less Demanding Compared to Healthy Boys , 2017, Journal of child neurology.

[23]  S. Sharp,et al.  Seasonal Variation in Children’s Physical Activity and Sedentary Time , 2016, Medicine and science in sports and exercise.

[24]  B. Darras Spinal muscular atrophies. , 2015, Pediatric clinics of North America.

[25]  P. S. Davies,et al.  Accuracy of Parent-Reported Energy Intake and Physical Activity Levels in Boys With Duchenne Muscular Dystrophy. , 2015, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[26]  A. Kornberg,et al.  Strong Correlation Between the 6-Minute Walk Test and Accelerometry Functional Outcomes in Boys With Duchenne Muscular Dystrophy , 2015, Journal of child neurology.

[27]  F. Endo,et al.  Estimation of muscle strength from actigraph data in Duchenne muscular dystrophy , 2014, Pediatrics international : official journal of the Japan Pediatric Society.

[28]  Nuala M. Byrne,et al.  Assessment of Physical Activity and Energy Expenditure: An Overview of Objective Measures , 2014, Front. Nutr..

[29]  Basel Kikhia,et al.  Optimal Placement of Accelerometers for the Detection of Everyday Activities , 2013, Sensors.

[30]  C. McDonald,et al.  Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases. , 2012, Physical medicine and rehabilitation clinics of North America.

[31]  Shigeru Inoue,et al.  The pandemic of physical inactivity: global action for public health , 2012, The Lancet.

[32]  Cindy Hamil,et al.  Evidence‐based path to newborn screening for duchenne muscular dystrophy , 2012, Annals of neurology.

[33]  Rieko Osu,et al.  Quantifying the quality of hand movement in stroke patients through three-dimensional curvature , 2011, Journal of NeuroEngineering and Rehabilitation.

[34]  David R Bassett,et al.  2011 Compendium of Physical Activities: a second update of codes and MET values. , 2011, Medicine and science in sports and exercise.

[35]  A. Bauman,et al.  Reliability and validity testing of a single-item physical activity measure , 2010, British Journal of Sports Medicine.

[36]  Sandra A Walsh,et al.  Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy. , 2005, Archives of physical medicine and rehabilitation.

[37]  M. Reeves,et al.  Seasonal variation in adult leisure-time physical activity. , 2003, Medicine and science in sports and exercise.

[38]  C. McDonald Physical activity, health impairments, and disability in neuromuscular disease. , 2002, American journal of physical medicine & rehabilitation.

[39]  T. Wienker,et al.  Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. , 2002, American journal of human genetics.

[40]  M. Ryan,et al.  Physical activity and the use of standard and complementary therapies in Duchenne and Becker muscular dystrophies. , 2016, Journal of pediatric rehabilitation medicine.

[41]  J. Montes,et al.  A Randomized, Controlled Clinical Trial of Exercise in Patients with Spinal Muscular Atrophy: Methods and Baseline Characteristics. , 2014, Journal of neuromuscular diseases.

[42]  Kamiar Aminian,et al.  Continuous monitoring and quantification of multiple parameters of daily physical activity in ambulatory Duchenne muscular dystrophy patients. , 2011, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[43]  P. Wollan,et al.  Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy. , 1996, Pediatric neurology.